Navigation Links
G-CON Manufacturing, Inc. Announces Maik Jornitz as President
Date:7/29/2014

Bryan, TX (PRWEB) July 29, 2014

G-CON Manufacturing Inc., the standard in design and production of autonomous modular cleanrooms, today announced a new leadership appointment designed to drive the company’s ambitious growth initiatives in the United States and abroad.

Maik Jornitz, Chief Operating Officer of G-Con Manufacturing, has been named as the company’s President charged with leading the pioneering company through its next phase of market growth.

“As we enter this stage of development and look forward to providing our next generation of products, having an experienced and forward thinking leader, like Maik, in this position is invaluable to our organization," said David Shanahan, Chief Executive Officer and Chairman of G-Con’s Board of Directors.

Jornitz joined G-CON in September 2012 as Vice President of Business Development. He was promoted to Chief Operating Officer in March 2013. Before joining G-CON, Jornitz was a Senior Vice President at Sartorius Stedim where he managed their global bioprocess product management and marketing. His career at Sartorius spanned 25 years.

Jornitz received a Masters of Engineering in Bioengineering at the University of Applied Sciences in Hamburg, Germany and successfully completed the PED program at IMD Business School in Lausanne, Switzerland.

In making the announcement, Shanahan further stated, “Since Maik joined G-CON Manufacturing, he has advanced our business into multiple target markets and broadened both the reach and quality of our products. His knowledge and experience within the biopharmaceutical industry has been invaluable. He is a proven leader with an exceptional track record and we are thrilled to have him in this position.”

About G-Con Manufacturing

G-CON was founded to address the fact that existing systems and methodologies for constructing biomanufacturing and personalized medicine suites were neither affordable nor flexible enough to meet the rapidly changing market's needs. G-CON's founders have significant experience in designing, building, operating, and maintaining a variety of traditional biomanufacturing facilities. They are familiar with the excessive cost to build, lack of flexibility, and high expense to maintain these traditional facilities and have leveraged this experience to create the G-CON POD™ solution. Moreover, the G-CON team understands that future facility designs must be multipurpose and repurposable, instead of fixed and specialized with ineffective capacity utilization.

For more information about G-Con, please visit the Company's website at http://www.gconbio.com.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12051552.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. GEA Process Engineering and G-CON Manufacturing Announce PCMM Collaboration with Pfizer
2. New 2 Hour Educational Learning Labs at MD&M West Will Feature Baxter Bioscience, BMW, Dell, GE Healthcare, Mattel, Northrup Grumman, Starbucks and Other Leading Groups in Design, Manufacturing, Engineering and Automation
3. Bright Future Ahead for Biopharmaceutical Contract Manufacturing, Says Frost & Sullivan
4. Pharma Contract Manufacturing, Research & Packaging Market a New Report Available at ReportsnReports.com
5. PI Ofers 6-Axis Nanopositioning Stage for Nano-Manufacturing, Microscopy, Nanomanipulation
6. Maine Manufacturing, LLC Announces Global Distribution of FAST® Protein Array Products
7. International Pipette Distributor, Pipette.com Announces the Addition of the Eppendorf Centrifuge 5427 R to Their Product Portfolio
8. Sapphire Energy Announces New CEO James Levine
9. WEDI’s HPID Workgroup Announces Release of Issue Brief: “What is the Difference Between a Health Plan and Payer?”
10. JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort
11. Texas Biocorridor Announces the Atlas Hotel, Centerpiece of Mixed Use Community for Biotech Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ("OncoSec") ... will host a Key Opinion Leader event to highlight ... oral and poster presentation at the upcoming 2017 ASCO-SITC ... KOL event will be held in-person and via live ... / 9:00 AM PST at the Lotte New York ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... portfolio to include an array of biochemical analyses critical for Lead Discovery. ... drive their hit-to-lead and SAR programs, including inhibitor potency and selectivity, mechanism of ...
(Date:2/23/2017)... ATLANTA , Feb. 23, 2017  In Atlanta, it ... art, fashion, and culture intertwine to create an expressive and ... often reflect this energy and contribute to it. ... , Hair Fairies seeks to carry on that ... The Atlanta salon is the newest ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® ... adults at home or in healthcare facilities during periods of rest. A lightweight, ...
Breaking Biology Technology:
(Date:1/30/2017)... 30, 2017   Invitae Corporation (NYSE: ... information companies, today announced that it will report its ... 2017 guidance on Monday, February 13, 2017, and Invitae,s ... at 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... briefly review financial results, guidance, and recent developments and ...
(Date:1/26/2017)... , Jan. 26, 2017  Acuity Market ... for Biometrics and Digital Identity".  Acuity characterizes 2017 ... identity when increased adoption reflects a new understanding ... "Biometrics and digital identity are often ... Maxine Most , Principal of Acuity Market ...
(Date:1/24/2017)... Jan. 24, 2017 Biopharm Reports has ... laboratory use of nuclear magnetic resonance spectroscopy (NMR). ... and profiled current practices, developments, trends and end-user ... as growth and opportunities. These areas include growth ... instruments, needs and innovation requirements, hyphenated NMR techniques, ...
Breaking Biology News(10 mins):